🇺🇸 FDA
Patent

US 8586626

Metabolites of wortmannin analogs and methods of using the same

granted A61PA61P35/00

Quick answer

US patent 8586626 (Metabolites of wortmannin analogs and methods of using the same) held by Arizona Board of Regents, Acting on Behalf of the University of Arizona expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents, Acting on Behalf of the University of Arizona
Grant date
Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00